Evidence map›Paper›PMID 25855670›Full record

ArticleReproduction (Cambridge, England)2015

Molecular analysis of the cumulus matrix: insights from mice with O-glycan-deficient oocytes.

Panayiota Ploutarchou, Pedro Melo, Anthony J Day, Caroline M Milner, Suzannah A Williams

Open access · hybridAbstract read
In one paragraph

Article in Reproduction (Cambridge, England), 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Formation of multiple-oocyte follicles in culture.In vitro cellular & developmental biology. Animal · 2017
    Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Panayiota PloutarchouNuffield Department of Obstetrics and GynaecologyWomen's Centre, Level 3, John Radcliffe Hospital, University of Oxford, Oxford OX3 9DU, UKFaculty of Life SciencesUniversity of Manchester, Michael Smith Building, Oxford Road, Manchester M13 9PT, UKWellcome Trust Centre for Cell-Matrix ResearchFaculty of Life Sciences, University of Manchester, Michael Smith Building, Oxford Road, Manchester M13 9PT, UK.
Pedro MeloNuffield Department of Obstetrics and GynaecologyWomen's Centre, Level 3, John Radcliffe Hospital, University of Oxford, Oxford OX3 9DU, UKFaculty of Life SciencesUniversity of Manchester, Michael Smith Building, Oxford Road, Manchester M13 9PT, UKWellcome Trust Centre for Cell-Matrix ResearchFaculty of Life Sciences, University of Manchester, Michael Smith Building, Oxford Road, Manchester M13 9PT, UK.
Anthony J DayNuffield Department of Obstetrics and GynaecologyWomen's Centre, Level 3, John Radcliffe Hospital, University of Oxford, Oxford OX3 9DU, UKFaculty of Life SciencesUniversity of Manchester, Michael Smith Building, Oxford Road, Manchester M13 9PT, UKWellcome Trust Centre for Cell-Matrix ResearchFaculty of Life Sciences, University of Manchester, Michael Smith Building, Oxford Road, Manchester M13 9PT, UK Nuffield Department of Obstetrics and GynaecologyWomen's Centre, Level 3, John Radcliffe Hospital, University of Oxford, Oxford OX3 9DU, UKFaculty of Life SciencesUniversity of Manchester, Michael Smith Building, Oxford Road, Manchester M13 9PT, UKWellcome Trust Centre for Cell-Matrix ResearchFaculty of Life Sciences, University of Manchester, Michael Smith Building, Oxford Road, Manchester M13 9PT, UK.
Caroline M MilnerNuffield Department of Obstetrics and GynaecologyWomen's Centre, Level 3, John Radcliffe Hospital, University of Oxford, Oxford OX3 9DU, UKFaculty of Life SciencesUniversity of Manchester, Michael Smith Building, Oxford Road, Manchester M13 9PT, UKWellcome Trust Centre for Cell-Matrix ResearchFaculty of Life Sciences, University of Manchester, Michael Smith Building, Oxford Road, Manchester M13 9PT, UK.
Suzannah A WilliamsNuffield Department of Obstetrics and GynaecologyWomen's Centre, Level 3, John Radcliffe Hospital, University of Oxford, Oxford OX3 9DU, UKFaculty of Life SciencesUniversity of Manchester, Michael Smith Building, Oxford Road, Manchester M13 9PT, UKWellcome Trust Centre for Cell-Matrix ResearchFaculty of Life Sciences, University of Manchester, Michael Smith Building, Oxford Road, Manchester M13 9PT, UK suzannah.williams@obs-gyn.ox.ac.uk.
University of Manchester · GBUniversity of Oxford · GB

Funding

Medical Research Council G0701180Wellcome Trust 088785
6 · The paper itself

Abstract

During follicle development, oocytes secrete factors that influence the development of granulosa and cumulus cells (CCs). In response to oocyte and somatic cell signals, CCs produce extracellular matrix (ECM) molecules resulting in cumulus expansion, which is essential for ovulation, fertilisation, and is predictive of oocyte quality. The cumulus ECM is largely made up of hyaluronan (HA), TNF-stimulated gene-6 (TSG-6, also known as TNFAIP6), pentraxin-3 (PTX3), and the heavy chains (HCs) of serum-derived inter-α-inhibitor proteins. In contrast to other in vivo models where modified expansion impairs fertility, the cumulus mass of C1galt1 Mutants, which have oocyte-specific deletion of core 1-derived O-glycans, is modified without impairing fertility. In this report, we used C1galt1 Mutant (C1galt1(FF):ZP3Cre) and Control (C1galt1(FF)) mice to investigate how cumulus expansion is affected by oocyte-specific deletion of core 1-derived O-glycans without adversely affecting oocyte quality. Mutant cumulus-oocyte complexes (COCs) are smaller than Controls, with fewer CCs. Interestingly, the CCs in Mutant mice are functionally normal as each cell produced normal levels of the ECM molecules HA, TSG-6, and PTX3. However, HC levels were elevated in Mutant COCs. These data reveal that oocyte glycoproteins carrying core 1-derived O-glycans have a regulatory role in COC development. In addition, our study of Controls indicates that a functional COC can form provided all essential components are present above a minimum threshold level, and thus some variation in ECM composition does not adversely affect oocyte development, ovulation or fertilisation. These data have important implications for IVF and the use of cumulus expansion as a criterion for oocyte assessment.

Indexed as

AnimalsCells, CulturedCumulus CellsExtracellular MatrixFemaleFertilizationGalactosyltransferasesImmunoenzyme TechniquesMiceMice, KnockoutOocytesOvarian FollicleOvulationPolysaccharidesReal-Time Polymerase Chain ReactionReverse Transcriptase Polymerase Chain ReactionC1galt1 protein, mouseGalactosyltransferasesPolysaccharidesRNA, Messenger

Identifiers

PMID25855670
PMCPMC4397614
OpenAlexW2128624530

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.